Literature DB >> 12684920

Extensive retinal neovascularization as a late finding in human immunodeficiency virus-infected patients with immune recovery uveitis.

Mary E Wright1, Daniel L Suzman, Karl G Csaky, Henry Masur, Michael A Polis, Michael R Robinson.   

Abstract

Sixteen human immunodeficiency virus (HIV)-infected patients with inactive cytomegalovirus (CMV) retinitis who had discontinued systemic anti-CMV therapy while receiving highly active antiretroviral therapy (HAART) were prospectively observed. Fifteen patients developed immune recovery uveitis (IRU); 3 of the patients developed extensive retinal neovascularization, 1 of whom required vitrectomy for recurrent vitreous hemorrhages. These late complications indicate a need for continued ophthalmologic follow-up of HIV-infected patients who have a history of CMV retinitis, even for individuals who have not required anti-CMV therapy for >4 years.

Entities:  

Mesh:

Year:  2003        PMID: 12684920     DOI: 10.1086/374050

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management.

Authors:  Lisa Barrett; Sharon Walmsley
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

2.  Immune recovery uveitis associated with highly active antiretroviral therapy in a patient with CMV retinitis and AIDS despite a low CD4+ T cell count: case report and a review of the literature.

Authors:  Mehmet Numan Alp; Nurcan Baykam; Gulcan Kural
Journal:  Int Ophthalmol       Date:  2009-02-07       Impact factor: 2.031

Review 3.  Immune recovery uveitis: pathogenesis, clinical symptoms, and treatment.

Authors:  Beata Urban; Alina Bakunowicz-Łazarczyk; Marta Michalczuk
Journal:  Mediators Inflamm       Date:  2014-06-24       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.